🔎 Trials Near Me

Home › Degenerasyon ng Macula › Washington › Spokane

Pag-aaral pangklinika para sa Degenerasyon ng Macula sa Spokane, WA

Isang pag-aaral para sa Degenerasyon ng Macula ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Spokane. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

Nagre-recruitPhase 2/3
  • Spokane Eye Clinical Research, Spokane
Edad 60 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT06635148

A Phase 1/2 Study of the Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Nagre-recruitPhase 1/2
  • Spokane Eye Clinic, Spokane
Edad 55 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07029945

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

Nagre-recruitPhase 2/3
  • Spokane Eye Clinical Research (Site 075), Spokane
Edad 50 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT07440225

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

Nagre-recruitPhase 3
  • Spokane Eye Clinical Research, Spokane
Edad 50 hanggang 85 · Lahat ng kasarian · Na-update Set 18, 2026 · NCT06541704

A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration

Nagre-recruitPhase 1
  • Spokane Eye Clinical Research, Spokane
Edad 50 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT03178149

Pag-aaral para sa Degenerasyon ng Macula sa ibang lungsod

Iba pang pag-aaral sa Spokane

Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.